To test whether WT p53 binds this site, CPT-treated normal-like breast epithelial cells (HBL-100) and DU4475 breast cancer cells were subjected to ChIP assays using p53 antibody (DO-1) or a control IgG. The gene discussed is TP53; the disease is breast carcinoma.